Sector
PharmaceuticalsOpen
₹998Prev. Close
₹1,002Turnover(Lac.)
₹8,567.59Day's High
₹1,002.7Day's Low
₹930.352 Week's High
₹1,36052 Week's Low
₹722.05Book Value
₹61.18Face Value
₹1Mkt Cap (₹ Cr.)
36,118.16P/E
132.96EPS
7.1Divi. Yield
029 Oct 2024
12:00 AM
EGM
13 Jul 2024
12:00 AM
AGM
Announcement Date: 13 Jul, 2024
26 Mar 2025
12:00 AM
Board Meeting
Agenda : Audited Result
12 Jul 2024
12:00 AM
BookCloser
Revenue from operations of the company stood at ₹307.2 crore, with a Year-on-Year (YoY) growth of 39.8% quarter over Q3 FY24 as compared to ₹219.8 crore
Suven is now a prominent player in the ADC outsourcing market, estimated to be worth $2.7 billion (approx. ₹22,815 Crore).
Here are some of the stocks that may see significant price movement today: Adani Enterprises, Siemens, Aurobindo Pharma, etc.
Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 25.46 | 25.46 | 25.46 | 25.46 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,030.44 | 1,723.92 | 1,495.24 | 1,039.73 |
Net Worth | 2,055.9 | 1,749.38 | 1,520.7 | 1,065.19 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Revenue | 1,320.22 | 1,009.71 | 833.78 | 0 |
yoy growth (%) | 30.75 | 21.09 | 0 | |
Raw materials | -399.1 | -301.94 | -229.18 | 0 |
As % of sales | 30.23 | 29.9 | 27.48 | 0 |
Employee costs | -100.48 | -76.23 | -73.72 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Profit before tax | 722.44 | 413.97 | 357.59 | -0.02 |
Depreciation | -39.09 | -31.63 | -23.86 | 0 |
Tax paid | -164.34 | -105.33 | -87.51 | 0 |
Working capital | 215.89 | 16.14 | -52.93 | |
Other operating items |
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,197.58 | 1,051.35 | 1,340.33 | 1,320.22 | 1,009.72 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,197.58 | 1,051.35 | 1,340.33 | 1,320.22 | 1,009.72 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 58.56 | 61.91 | 46.36 | 133.49 | 67.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Shweta Jalan
Independent Director
U B Pravin Rao
Managing Director
Venkatanaga Kali Vara Prasad Raju Vetukuri
Non Executive Director
Pankaj Patwari
Independent Director
Matangi Gowrishankar
Independent Director
Vinod Rao
Independent Director
K G Ananthakrishnan
Executive Chairman & Director
VIVEK SHARMA
Company Sec. & Compli. Officer
Kundan Kumar Jha
Additional Director
Jaishankar Krishnan
Additional Director
Vinod Padikkal
8-2-334 SDE Serene Chambers,
3 Floor Avenue 7 Road No 5,
Telangana - 500034
Tel: 91-40-23549414/1142/3311
Website: http://www.suvenpharm.com
Email: [email protected]
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: [email protected]
Summary
Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors. The Companys com...
Read More
Reports by Suven Pharmaceuticals Ltd
What is the Cohance Lifesciences Ltd share price today?
What is the Market Cap of Cohance Lifesciences Ltd?
What is the PE and PB ratio of Cohance Lifesciences Ltd?
What is the 52 Week High and Low of Cohance Lifesciences Ltd?
What is the CAGR of Cohance Lifesciences Ltd?
What is the shareholding pattern of Cohance Lifesciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
